SCHEMBL2508784

SCHEMBL2508784

Nc1ncnc2c1ncn2[C@H]1CC(O)[C@@H](COP(=O)(O)OP(=O)(O)O)O1

nearest known ligand 0.81

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.81
P2RY1 P47900 5/20 0.74
ENPP1 P22413 3/20 0.74
P2RX1 P51575 4/20 0.68
P2RX3 P56373 4/20 0.68
P2RX2 Q9UBL9 2/20 0.68
P2RX4 Q99571 3/20 0.66
P2RY2 P41231 2/20 0.66
SRC P12931 1/20 0.66
ALDH1A1 P00352 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
DTYMK P23919 2/20 0.65
RNASEL Q05823 1/20 0.63
MACROD2 A1Z1Q3 1/20 0.61
SIRT6 Q8N6T7 1/20 0.61
MACROD1 Q9BQ69 1/20 0.61
TRPM2 O94759 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL77641 1.00 POLB (0.81) POLBP2RY1ENPP1P2RX1P2RX3
SCHEMBL31211719 1.00 POLB (0.81) POLBP2RY1ENPP1P2RX1P2RX3
SCHEMBL29352481 1.00 POLB (0.81) POLBP2RY1ENPP1P2RX1P2RX3
SCHEMBL889289 0.99 POLB (0.80) POLBP2RY1ENPP1P2RX1P2RX3
SCHEMBL703733 0.99 POLB (0.80) POLBP2RY1ENPP1P2RX1P2RX3
SCHEMBL18785117 0.99 POLB (0.80) POLBP2RY1ENPP1P2RX1P2RX3
SCHEMBL14471000 0.99 POLB (0.80) POLBP2RY1ENPP1P2RX1P2RX3
SCHEMBL5044161 0.99 POLB (0.80) POLBP2RY1ENPP1P2RX1P2RX3
SCHEMBL78250 0.99 POLB (0.80) POLBP2RY1ENPP1P2RX1P2RX3
SCHEMBL29350133 0.99 POLB (0.80) POLBP2RY1ENPP1P2RX1P2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072741-A1 PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-04-03 WO claimed
US-20050136673-A1 CMP slurry XU WEN-QING (US) 2005-06-23 US claimed
US-20050028450-A1 CMP slurry XU WEN-QING (US) 2005-02-10 US claimed
EP-0577266-A2 Method for preparing (gamma-32p) labeled nucleotides by enzymatic conversion of dihydroxyacetone phosphate to 3-phosphoglycerate ICN BIOMEDICALS INC. (US) 1994-01-05 EP claimed
US-4209589-A Enzymatic process for preparing [γ-32 P]-labeled nucleotides VANDERBILT UNIVERSITY (US) 1980-06-24 US claimed
WO-2025072741-A1 PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-04-03 WO disclosed
US-20140309186-A1 Metabolomics-Based Identification of Disease-Causing Agents GEORGIA TECH RESEARCH CORPORATION 2014-10-16 US disclosed
US-20110246081-A1 Metabolomics-Based Identification of Disease-Causing Agents GEORGIA TECH RESEARCH CORPORATION (US) 2011-10-06 US disclosed
US-20090186358-A1 Pathway Analysis of Cell Culture Phenotypes and Uses Thereof WYETH (US) 2009-07-23 US disclosed
US-20050136673-A1 CMP slurry XU WEN-QING (US) 2005-06-23 US disclosed
US-20050028450-A1 CMP slurry XU WEN-QING (US) 2005-02-10 US disclosed
EP-0577266-A2 Method for preparing (gamma-32p) labeled nucleotides by enzymatic conversion of dihydroxyacetone phosphate to 3-phosphoglycerate ICN BIOMEDICALS INC. (US) 1994-01-05 EP disclosed
US-5087565-A Synthetic process for preparation of 32 P-labeled nucleotides DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-02-11 US disclosed